Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar michaeltbryant (< 20) Submitted: 9/19/2009 8:47:21 AM : Outperform Start Price: $7.05 ENZ Score: -96.67

Up on huge volume.

Featured Broker Partners


Advertisement